TBIO
Telesis Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 27th of September, 2024.
32 hedge funds and large institutions have $20.9M invested in Telesis Bio, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$736K | |
| 2 | +$241K | |
| 3 | +$194K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 5 |
PM
Penbrook Management
New York
|
+$137K |
Top Sellers
| 1 | -$4.28M | |
| 2 | -$275K | |
| 3 | -$180K | |
| 4 |
Millennium Management
New York
|
-$113K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$57K |